<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?</title>
  <description>In the first episode of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress series, we spoke with co-authors Jeffrey Sparks, MD, and Zachary Wallace, MD, about their research – the association between disease-modifying antirheumatic drug (DMARD) use and COVID-19 outcomes in rheumatoid arthritis (RA) – conducted on behalf of the COVID-19 Global Rheumatology Alliance. The  study was presented by Dr Sparks and Dr Wallace at the EULAR 2021 meeting and has been published in BMJ.&amp;amp;nbsp; </description>
  <author_name>Rheum Advisor on Air</author_name>
  <author_url>http://rheumonair.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/19645094/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/106383896</thumbnail_url>
</oembed>
